 |
 |
[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[e-drug] ARV parallel export from Africa to Europe (cont)
- Subject: [e-drug] ARV parallel export from Africa to Europe (cont)
- From: [email protected]
- Date: Tue, 8 Oct 2002 23:26:35 -0400 (EDT)
E-drug: ARV parallel export from Africa to Europe (cont)
---------------------------------------------
Yes this strategy of packaging products differently is definitely enough to
prevent backflow. To me the responsibility for this problem of ARV's for
Africa rests entirely with the companies. They already segment
markets and register the same products for different markets using
packaging, labelling and even coloring. Same molecule different
presentation.
Richard
Richard Laing
Associate Professor of International Health
Boston University School of Public Health
715 Albany St, T4W, Boston MA 02118 USA
Tel 617 414-1444 Fax 617 638-4476
E-mail [email protected]
--
To send a message to E-Drug, write to: [email protected]
To subscribe or unsubscribe, write to: [email protected]
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: [email protected]
Information and archives: http://www.healthnet.org/programs/edrug.html
|
